J
Jean G. Diodati
Researcher at Université de Montréal
Publications - 27
Citations - 1707
Jean G. Diodati is an academic researcher from Université de Montréal. The author has contributed to research in topics: Clopidogrel & Aspirin. The author has an hindex of 14, co-authored 27 publications receiving 1581 citations. Previous affiliations of Jean G. Diodati include Montreal Heart Institute.
Papers
More filters
Journal ArticleDOI
Resistance to clopidogrel: a review of the evidence.
TL;DR: Because there is no single and validated platelet function assay to measure clopidogrel's antiplatelet effect, it is not justified to routinely look for clopIDogrel resistance in the clinical setting.
Journal ArticleDOI
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
Marie Lordkipanidzé,Chantal Pharand,Erick Schampaert,Jacques Turgeon,Donald A. Palisaitis,Jean G. Diodati +5 more
TL;DR: Six major platelet function tests are not equally effective in measuring aspirin's antiplatelet effect and correlate poorly amongst themselves, and the clinical usefulness of the different assays to classify correctly patients as aspirin resistant remains undetermined.
Journal ArticleDOI
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
Shamir R. Mehta,Kevin R. Bainey,Warren J. Cantor,Marie Lordkipanidzé,Guillaume Marquis-Gravel,Simon D. Robinson,Matthew Sibbald,Derek So,Graham C. Wong,Joseph Abunassar,Margaret L. Ackman,Alan Bell,Raymond Cartier,James D. Douketis,Patrick R. Lawler,Michael Sean McMurtry,Jacob A. Udell,Sean van Diepen,Subodh Verma,G.B. John Mancini,John A. Cairns,Jean-François Tanguay,Paul W. Armstrong,Akshay Bagai,Claudia Bucci,Jean-Pierre Déry,Jean G. Diodati,Jocelyn Dupuis,David Fitchett,Michael P. Love,Robert C. Welsh +30 more
TL;DR: The present update to the 2011 and 2013 Canadian Cardiovascular Society APT guidelines incorporates new evidence on how to optimize APT use, particularly in situations in which few to no data were previously available.
Journal ArticleDOI
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients
Marie Lordkipanidzé,Chantal Pharand,Thuy Anh Nguyen,Erick Schampaert,Donald A. Palisaitis,Jean G. Diodati +5 more
TL;DR: The assessment of platelet function inhibition by clopidogrel is highly test-specific, thus highlighting the need for unambiguous guidelines with respect to assay selection, as Platelet function assays are not interchangeable.
Journal ArticleDOI
Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.
TL;DR: The possibility of a pharmacological rebound phenomenon which could lead to adverse ischemic events is unveiled, and the warning against premature discontinuation of antiplatelet drugs issued in current guidelines is supported.